1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. California >
  6. KalVista Acquires Carbylan Therapeutics

M&A Deal Summary

KalVista Acquires Carbylan Therapeutics

On June 1, 2016, KalVista acquired medical products company Carbylan Therapeutics

Acquisition Highlights
  • This is KalVista’s 1st transaction in the Medical Products sector.
  • This is KalVista’s 1st transaction in the United States.
  • This is KalVista’s 1st transaction in California.

M&A Deal Summary
Date 2016-06-01
Target Carbylan Therapeutics
Sector Medical Products
Buyer(s) KalVista
Deal Type Merger

Target

Carbylan Therapeutics

Palo Alto, California, United States
Carbylan Therapeutics develops and markets medical devices and device/drug combination products based on novel chemically engineered polymer systems incorporating hyaluronic acid, a well-known polysaccharide widely present in the human body.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

KalVista

Cambridge, Massachusetts, United States
Category Company
Sector Life Science
Employees150
Revenue 132M USD (2024)
DESCRIPTION

KalVista is a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet need. KalVista is based in Cambridge, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal